Full Library

Return to list of results

IDSA COVID-19 Guideline, Part 4: Serologic Testing

RIS

Recommended format for most reference management software

BibTeX

Recommended format for BibTeX-specific software

Open in Zotero
View on zotero.org
Resource type
Web Page
Author/contributor
Title
IDSA COVID-19 Guideline, Part 4: Serologic Testing
Abstract
Serologic tests for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are now widely available. IDSA has developed recommendations related to the use of SARS-CoV-2 serologic testing in clinical practice and public health.
URL
https://www.idsociety.org/practice-guideline/covid-19-guideline-serology/
Accessed
12/2/20, 8:21 AM
Short Title
COVID-19 Guideline, Part 4
Language
en
Citation
Kimberly E. Hanson*, Angela M. Caliendo, Cesar A. Arias, Janet A. Englund, Mary K. Hayden, Mark J. Lee, Mark Loeb, Robin Patel, Osama Altayar**, Abdallah El Alayli**, Shahnaz Sultan**, Yngve Falck-Ytter**, Valéry Lavergne**, Rebecca L. Morgan**, M. Hassan. (n.d.). IDSA COVID-19 Guideline, Part 4: Serologic Testing. Retrieved December 2, 2020, from https://www.idsociety.org/practice-guideline/covid-19-guideline-serology/
GUIDELINES
ORGANISMS
Link to this record
https://transplantid.net/PUZTW4SH